Chemed (NYSE:CHE) Shares Down 4.9% – What’s Next?

Posted by Geri Gentry on Aug 27th, 2026

Shares of Chemed Corporation (NYSE:CHE – Get Free Report) fell 4.9% during mid-day trading on Thursday . The company traded as low as $519.51 and last traded at $521.5150. Approximately 131,404 shares were traded during trading, a decline of 39% from the average daily volume of 214,262 shares. The stock had previously closed at $548.56.

Analyst Ratings Changes

CHE has been the subject of a number of analyst reports. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Oppenheimer boosted their price target on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada increased their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Chemed currently has an average rating of “Hold” and a consensus price target of $530.75.

View Our Latest Report on Chemed

Chemed Price Performance

The firm has a market cap of $6.82 billion, a P/E ratio of 26.08, a PEG ratio of 2.06 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The company’s 50-day moving average is $506.04 and its two-hundred day moving average is $448.64.

Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This is an increase from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s payout ratio is presently 14.06%.

Insiders Place Their Bets

In other Chemed news, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $541.04, for a total value of $541,040.00. Following the sale, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. This trade represents a 6.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Chemed

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Monetary Solutions Ltd bought a new stake in shares of Chemed during the fourth quarter worth about $25,000. Los Angeles Capital Management LLC bought a new position in Chemed during the 4th quarter worth $26,000. BOK Financial Private Wealth Inc. acquired a new stake in shares of Chemed in the fourth quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Chemed during the second quarter worth about $34,000. Finally, Versant Capital Management Inc lifted its stake in shares of Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after acquiring an additional 75 shares during the period. Institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.